Sam Seddigh

Head of Employment & Benefits Partner
  • Stockholm
  • Languages:
    Swedish, English

Sam Seddigh is a Partner of Vinge’s Employment & Benefits team. He has extensive experience from having worked with a broad range of employment related matters for almost 15 years, including complex reorganisations and redundancies, termination matters, international outsourcings, transactions, pension matters and investigations. He also assists clients in disputes in both courts and arbitrations. He has a deep understanding and experience from the Tech and Energy sectors, having worked as an in-house counsel at Spotify, where he headed Spotify's EMEA Employment Law practice, and Vattenfall.

Practice Areas

Education

  • LLM, 2008

Experience

  • Roschier Law Firm, 2022-2023
  • Spotify AB, 2018-2022
  • Vattenfall AB, 2015-2018
  • Mannheimer Swartling Law Firm, 2009-2016

Mandates

Mandate September 19, 2024

Vinge advises Santander Consumer Finance in connection with the divestment of its Swedish and Norwegian Credit Card and Sales Financing business

Vinge has advised Santander Consumer Bank AS in connection with the sale of its Swedish and Norwegia…

Mandate September 03, 2024

Vinge advises Blue Wolf Capital Partners in connection with the acquisition of seven manufacturing and development facilities from Recipharm

Vinge has, together with Kirkland & Ellis, advised Blue Wolf Capital Partners LLC (“Blue Wolf”), a m…

Mandate May 23, 2024

Vinge advises Axcel in connection with the sale of Loopia Group to team.blue

Vinge advises Axcel V in connection with the sale of Loopia Group to team.blue, Europe’s leading dig…

Mandate May 13, 2024

Vinge advises EQT Infrastructure VI on its public offer for OX2

EQT Infrastructure VI, through its indirectly owned subsidiary Otello BidCo AB, announces a recommen…

Mandate October 18, 2023

Vinge advises Thermo Fisher in connection with the acquisition of Olink

Vinge has advised Thermo Fisher Scientific Inc., (”Thermo Fisher”), the world leader in serving scie…

Mandate September 27, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences…